Status:
COMPLETED
Modifications in Cardiovascular Risk Factors When Performing Physical Exercise in Hypertensive and Dyslipidemic Patients
Lead Sponsor:
Universidad Católica San Antonio de Murcia
Conditions:
Hypertension
Eligibility:
All Genders
40-65 years
Phase:
NA
Brief Summary
Single-center, randomized, parallel-group, controlled, open-label study. The aim of the study was to evaluate the effects of an exercise training program intervention of different intensities (high in...
Detailed Description
All participants included in the study were referred by their primary care physicians, who prescribed physical exercise as a healthy lifestyle intervention added to the antihypertensive regimens in th...
Eligibility Criteria
Inclusion
- Age between 40 and 65 years.
- Under treatment with at least one antihypertensive drug for hypertension. Treatment should have lasted at least 12 months prior to inclusion in the study.
- Diagnosed with dyslipidemia under pharmacological treatment or with a specific hypercholesterolemia (\> 200 mg/dL) in the past and a cholesterol level at the start of the study greater than 200 mg/dL.
- Patient in Primary Prevention.
- Subjects who do not develop physical exercise scheduled on a weekly basis.
- Subjects who have given written informed consent to participate in the study.
Exclusion
- Serious or terminal illnesses.
- Diagnosis of ischemic and/or cerebrovascular heart disease.
- Presence of chronic diseases that prevent the performance of a physical exercise program or a stress test (disabling arthropathies, chronic moderate/severe pneumopathies, arrhythmias, etc).
- Severe mental illnesses: psychosis, severe depressive disorder, neurosis.
- Diabetes mellitus.
- Presence of absolute or relative contraindications dictated by the American College of Sports Medicine (ACSM, 1995), during the performance of the stress tests.
- Pregnant or breast-feeding women
- Inability to understand the informed consent.
Key Trial Info
Start Date :
September 20 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04832048
Start Date
September 20 2016
End Date
December 20 2019
Last Update
April 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Catholic University of Murcia
Murcia, Spain, 30107